Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease
Table 3
Procedural details in different treatment groups.
Variable
EVT - Selective Stenting
EVT- Routine Stenting
CFE
n (%)
n (%)
n (%)
Total stents
123
330
552∞
Balloon-Expandable stents
15/110 (13.6) #
93 (28.2)
DNA
Self-Expandable stents
95 /110 (86.4) #
237 (71.8)
DNA
Bioabsorbable stents
0 (0)
41 (12.4)
DNA
Covered stents
0 (0)
17 (5.1)
DNA
Atherectomy
72 (10.6)
15 (4.9)
DNA
Contralateral cross-over approach
479 (70.6)
239 (78.1)
DNA
Ipsilateral retrograde approach
104 (15.3)
38 (12.4)
DNA
Stent Fracture
0 (0)
6 (1.8)
DNA
Stent Re puncture
2 (1.6)
24 (7.2)
DNA
CFE only
DNA
DNA
944 (48.9)
Hybrid CFE (CFE + endovascular procedure)
DNA
DNA
794 (41.1)
CFE + Distal Revascularization
DNA
DNA
401/1721 (23.3) ƍ
CFE + Proximal Revascularization
DNA
DNA
495/1721 (28.7) ƍ
CFE + Proximal and Distal Revascularization
DNA
DNA
81/1683 (4.8) π
Patch angioplasty
DNA
DNA
1325/ 1837 (72.1)
Profundaplasty
DNA
DNA
414/743 (55.7) φ
Concomitant Bypass
DNA
DNA
110 (5.6)
[# 7 out of 8 studies | π 11 out of 13 studies | ƍ 12 out of 13 studies | 12 out of 13 studies | ∞ concomitant proximal or distal stents (not in CFA)] DNA-Does not apply.
